353
Views
18
CrossRef citations to date
0
Altmetric
Original

A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo

, , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 141-154 | Received 02 Dec 2008, Accepted 23 Feb 2009, Published online: 11 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Karin Taylor, Christopher B Howard, Martina L Jones, Ilya Sedliarou, Jennifer MacDiarmid, Himanshu Brahmbhatt, Trent P Munro & Stephen M Mahler. (2015) Nanocell targeting using engineered bispecific antibodies. mAbs 7:1, pages 53-65.
Read now
Francesca Walker, Julie Rothacker, Christine Henderson, Edouard C. Nice, Bruno Catimel, Hui-Hua Zhang, Andrew M. Scott, Michael F. Bailey, Suzanne G. Orchard, Timothy E. Adams, Zhanqi Liu, Thomas P.J. Garrett, Andrew H.A. Clayton & Antony W. Burgess. (2012) Ligand binding induces a conformational change in epidermal growth factor receptor dimers. Growth Factors 30:6, pages 394-409.
Read now
Eva J. Koziolek, Jacqueline F. Donoghue, John D. Bentley, George Lovrecz, Olan Dolezal, Colin W. Ward, Julie Rothacker, Edouard C. Nice, Antony W. Burgess, M. Hafner, Terrance G. Johns & Timothy E. Adams. (2012) A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation. Growth Factors 30:5, pages 310-319.
Read now
Nicholas C Nicolaides, Philip M Sass & Luigi Grasso. (2010) Advances in targeted therapeutic agents. Expert Opinion on Drug Discovery 5:11, pages 1123-1140.
Read now

Articles from other publishers (14)

Kelly Karl, Taylor P. Light & Kalina Hristova. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 10 36 .
Ruth A. Mitchell, Rodney B. Luwor & Antony W. Burgess. (2018) Epidermal growth factor receptor: Structure-function informing the design of anticancer therapeutics. Experimental Cell Research 371:1, pages 1-19.
Crossref
Miles A. Miller, Marcia L. Moss, Gary Powell, Robert Petrovich, Lori Edwards, Aaron S. Meyer, Linda G. Griffith & Douglas A. Lauffenburger. (2015) Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain. Scientific Reports 5:1.
Crossref
Stephen Goodall, Christopher B. Howard, Martina L. Jones, Trent Munro, Zhongfan Jia, Michael J. Monteiro & Stephen Mahler. (2015) An EGFR targeting nanoparticle self assembled from a thermoresponsive polymer. Journal of Chemical Technology & Biotechnology 90:7, pages 1222-1229.
Crossref
Yibin Xu, Priscilla Soo, Francesca Walker, Hui Hua Zhang, Nicholas Redpath, Chin Wee Tan, Nicos A. Nicola, Timothy E. Adams, Thomas P. Garrett, Jian-Guo Zhang & Antony W. Burgess. (2015) LRIG1 Extracellular Domain: Structure and Function Analysis. Journal of Molecular Biology 427:10, pages 1934-1948.
Crossref
S A Greenall, J F Donoghue, N G Gottardo, T G Johns & T E Adams. (2014) Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivo.. Oncogene 34:13, pages 1658-1666.
Crossref
Jiali Zhai, Judith A. Scoble, Nan Li, George Lovrecz, Lynne J. Waddington, Nhiem Tran, Benjamin W. Muir, Gregory Coia, Nigel Kirby, Calum J. Drummond & Xavier Mulet. (2015) Epidermal growth factor receptor-targeted lipid nanoparticles retain self-assembled nanostructures and provide high specificity. Nanoscale 7:7, pages 2905-2913.
Crossref
Nicholas J. Bessman, Atrish Bagchi, Kathryn M. Ferguson & Mark A. Lemmon. (2014) Complex Relationship between Ligand Binding and Dimerization in the Epidermal Growth Factor Receptor. Cell Reports 9:4, pages 1306-1317.
Crossref
V. Chandana Epa, Olan Dolezal, Larissa Doughty, Xiaowen Xiao, Christian Jost, Andreas Plückthun & Timothy E. Adams. (2013) Structural Model for the Interaction of a Designed Ankyrin Repeat Protein with the Human Epidermal Growth Factor Receptor 2. PLoS ONE 8:3, pages e59163.
Crossref
M Lindzen, S Carvalho, A Starr, N Ben-Chetrit, C-R Pradeep, W J Köstler, A Rabinkov, S Lavi, S S Bacus & Y Yarden. (2011) A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis. Oncogene 31:30, pages 3505-3515.
Crossref
Sameer A. Greenall, Ermanno Gherardi, Zhanqi Liu, Jacqueline F. Donoghue, Angela A. Vitali, Qian Li, Roger Murphy, Luisa Iamele, Andrew M. Scott & Terrance G. Johns. (2012) Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET. PLoS ONE 7:4, pages e34658.
Crossref
Tsun-Wen Yao, Woo-Shin Kim, Denise MT. Yu, George Sharbeen, Geoffrey W. McCaughan, Kang-Yell Choi, Pu Xia & Mark D. Gorrell. (2011) A Novel Role of Dipeptidyl Peptidase 9 in Epidermal Growth Factor Signaling. Molecular Cancer Research 9:7, pages 948-959.
Crossref
Maria-del-Mar Inda, Rudy Bonavia, Akitake Mukasa, Yoshitaka Narita, Dinah W.Y. Sah, Scott Vandenberg, Cameron Brennan, Terrance G. Johns, Robert Bachoo, Philipp Hadwiger, Pamela Tan, Ronald A. DePinho, Webster Cavenee & Frank Furnari. (2010) Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes & Development 24:16, pages 1731-1745.
Crossref
Diego Alvarado, Daryl E. Klein & Mark A. Lemmon. (2010) Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor. Cell 142:4, pages 568-579.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.